A hearty solution

 
Published: Saturday 04 July 2015

Transmyocardial laser revascularisation (TMR), a new technique for creating channels in the left ventricular wall to improve blood supply to the damaged heart muscle, offers new hope to those suffering from heart disease. Heart patients who are unfit to undergo a coronary artery bypass graft or percutaneous transluminal coronary angioplasty, can benefit from TMR, which uses high-power CO 2 laser. PLC systems of Cambridge, Massachusetts, US, which has already carried out encouraging tests on over 200 patients with endstage coronary artery disease, is expecting the US Food and Drug Administration's approval to start marketing the laser device.

Subscribe to Weekly Newsletter :

Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.